BRNS · Categories · Form 4
BRNS - SEC Form 4 insider transactions
Barinthus Biotherapeutics plc (BRNS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for BRNS
- Amendment: Former 10% owner Oxford Science Enterprises Plc closing all direct ownership in the company (SEC Form 4)4/A - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Scheeren Joseph returned 23,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Phillips Anne M. returned 3,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Wright Robin returned 48,256 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Morgon Pierre A. returned 10,506 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Hammacher Alex returned 3,000 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Chief Medical Officer Hooftman Leon was granted 361,530 units of Ordinary Shares and returned 361,530 units of Ordinary Shares to the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Chief Executive Officer Enright William returned 1,243,377 units of Ordinary Shares to the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- Director Dawes Karen A returned 1,700 units of Ordinary Shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Hammacher Alex4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Wright Robin4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Morgon Pierre A.4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Phillips Anne M.4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Scheeren Joseph4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Director Dawes Karen A4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Financial Officer Brown Gemma4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Executive Officer Enright William4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Business Officer Griffiths Graham4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Hooftman Leon4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Hooftman Leon4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Dawes Karen A4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Scheeren Joseph4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Phillips Anne M.4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Hammacher Alex4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Morgon Pierre A.4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SEC Form 4 filed by Wright Robin4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)